✦ LIBER ✦

NMR structure-based drug design

✍ Scribed by Stephen W. Fesik

Publisher: Springer Netherlands
Year: 1993
Tongue: English
Weight: 619 KB
Volume: 3
Category: Article
ISSN: 0925-2738
DOI: 10.1007/bf00212513

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure-based drug design

✍ L Mario Amzel 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 338 KB

NMR Spectroscopy Tools for Structure-Aid

NMR Spectroscopy Tools for Structure-Aided Drug Design.

✍ Steve W. Homans 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 67 KB

NMR Spectroscopy Tools for Structure-Aid

NMR Spectroscopy Tools for Structure-Aided Drug Design

✍ Steve W. Homans 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

## Abstract Biomolecular NMR spectroscopy has expanded dramatically in recent years and is now a powerful tool for the study of structure, dynamics, and interactions of biomolecules. Previous limitations with respect to molecular size are no longer a primary barrier, and systems as large as 900 kDa

Recent developments in structure-based d

Recent developments in structure-based drug design

✍ Gerhard Klebe 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 340 KB

Drug Discovery Research || Molecular Doc

Drug Discovery Research || Molecular Docking and Structure-Based Design

✍ Huang, Ziwei 📂 Article 📅 2007 🏛 John Wiley & Sons, Inc. ⚖ 920 KB

Thymidylate synthase inhibition: A struc

Thymidylate synthase inhibition: A structure-based rationale for drug design

✍ M. Paola Costi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

Thymidylate synthase (TS) is a very interesting target in antiproliferative diseases. Its inhibition causes thimineless death of the cells and compounds inhibiting TS are widely used in anticancer therapy. The classical antifolate TS inhibitors are structural analogs of the folate cofactor; they oft